- Home
- FVR vs ICUCW Comparison
FVR vs ICUCW Comparison
Compare FVR & ICUCW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FVR
- ICUCW
- Stock Information
- Founded
- FVR 2016
- ICUCW N/A
- Country
- FVR United States
- ICUCW United States
- Employees
- FVR N/A
- ICUCW 19
- Industry
- FVR
- ICUCW Biotechnology: Pharmaceutical Preparations
- Sector
- FVR
- ICUCW Health Care
- Exchange
- FVR NYSE
- ICUCW Nasdaq
- Market Cap
- FVR N/A
- ICUCW N/A
- IPO Year
- FVR 2024
- ICUCW 2021
- Fundamental
- Price
- FVR $11.50
- ICUCW $0.03
- Analyst Decision
- FVR Strong Buy
- ICUCW
- Analyst Count
- FVR 5
- ICUCW 0
- Target Price
- FVR $20.80
- ICUCW N/A
- AVG Volume (30 Days)
- FVR 218.4K
- ICUCW N/A
- Earning Date
- FVR 05-14-2025
- ICUCW N/A
- Dividend Yield
- FVR 5.59%
- ICUCW N/A
- EPS Growth
- FVR N/A
- ICUCW N/A
- EPS
- FVR N/A
- ICUCW N/A
- Revenue
- FVR $60,901,000.00
- ICUCW N/A
- Revenue This Year
- FVR $20.10
- ICUCW N/A
- Revenue Next Year
- FVR $8.63
- ICUCW N/A
- P/E Ratio
- FVR N/A
- ICUCW N/A
- Revenue Growth
- FVR 15.85
- ICUCW N/A
- 52 Week Low
- FVR $10.61
- ICUCW N/A
- 52 Week High
- FVR $19.76
- ICUCW N/A
- Technical
- Relative Strength Index (RSI)
- FVR N/A
- ICUCW N/A
- Support Level
- FVR N/A
- ICUCW N/A
- Resistance Level
- FVR N/A
- ICUCW N/A
- Average True Range (ATR)
- FVR 0.00
- ICUCW 0.00
- MACD
- FVR 0.00
- ICUCW 0.00
- Stochastic Oscillator
- FVR 0.00
- ICUCW 0.00
About ICUCW SeaStar Medical Holding Corporation Warrant
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.